Dapagliflozin vs Rituximab
Dapagliflozin vs Rituximab: Overview
This comparison examines the pharmacological differences between Dapagliflozin and Rituximab.
Mechanism of Action
Dapagliflozin: Selective SGLT2 inhibitor reducing renal glucose and sodium reabsorption.
Rituximab: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.
Pharmacokinetics
Half-life: Dapagliflozin — 12.9 hours; Rituximab — 22 days.
Chemical Properties
Molecular Formula: Dapagliflozin — C21H25ClO6.
Molecular Weight: Dapagliflozin — 408.8730 g/mol.
Type: Dapagliflozin — Small molecule; Rituximab — Antibody.